Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Opsens Inc
T.OPS
Healthcare
Medical Devices
OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR...
) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:OPS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(18)
•••
GoldenArm1
X
View Profile
View Bullboard History
Post by
GoldenArm1
on Mar 11, 2024 5:26pm
ITYS
I told you so. Saw the writing on the wall on this and got out pretty much close to buy out price. Second time this has happened to me and yeah I made money but it seems Canadian Tech co can only get
...more
(8)
•••
Shyl19
X
View Profile
View Bullboard History
Comment by
Shyl19
on Dec 14, 2023 12:29am
RE:RE:Rookie question here!
Really appreciated !!
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company
posted Dec 22, 2024 9:00am by
Voyageur Pharmaceuticals Ltd
-
|
Voyageur is securing supply chains in North America for barium, iodine and fullerene drug development and is aiming to gain efficiencies in production of contrast media products. The company anticipates this LOI will expand Voyageur’s project portfolio and diversify the Company’s product mix. The global contrast media market is valued at $6.3 billion with GE HealthCare projecting it will double over the next decade. ...read more
(441)
•••
TeamEddie
X
View Profile
View Bullboard History
Comment by
TeamEddie
on Dec 13, 2023 11:35am
RE:Rookie question here!
you can wait and they will put the $2.9 per share into your acct or if its still trading the bid is 2.89 I would just sell at $2.89
(8)
•••
Shyl19
X
View Profile
View Bullboard History
Post by
Shyl19
on Dec 13, 2023 11:30am
Rookie question here!
With wealthsimple, do we have to do something with the shares to get paid ? Or, we just let the process go through ? Thanks in advance.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 12, 2023 6:01am
New Press Release - HAEMONETICS COMPLETES ACQUISITION OF OPSENS
All amounts in this press release are in Canadian dollars.QUÉBEC CITY, Dec. 12, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, is pleased...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 08, 2023 7:00am
New Press Release - OPSENS RECEIVES FINAL ORDER FOR ARRANGEMENT WITH HAEMONETICS
All amounts in this press release are in Canadian dollars.QUÉBEC CITY, Dec. 8, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, announces...
read article.
(77)
•••
ivebeenthere
X
View Profile
View Bullboard History
Comment by
ivebeenthere
on Dec 02, 2023 8:06pm
RE:faster close
It's no good for me i liquidated half of my shares thinking thats my profit would be spreaded between 2023 and 2024 but that wont be the case.Ill pay dearly for that.
(1974)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on Dec 01, 2023 2:59pm
faster close
it is currently expected that the Arrangement will be completed by mid-December 2023 Used to be Q1
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 01, 2023 1:49pm
New Press Release - OPSENS' SHAREHOLDERS APPROVE ARRANGEMENT WITH HAEMONETICS
All amounts in this press release are in Canadian dollars.QUÉBEC CITY, Dec. 1, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, is pleased to...
read article.
(39)
•••
tannin
X
View Profile
View Bullboard History
Comment by
tannin
on Nov 29, 2023 7:21pm
RE:RE:RE:RE:OPSENS ANNOUNCES FOURTH QUARTER RESULTS
Appreciate your thoughts Possibleidiot..........Will do some work on those names. Currently nervous given my take on where we are in the economic cycle......nervous in the sense of, buying high flyers
...more
(1974)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Comment by
Possibleidiot01
on Nov 28, 2023 7:11am
RE:RE:RE:OPSENS ANNOUNCES FOURTH QUARTER RESULTS
tannin I sent this message awhile back to somebody on another board who never bothered to pick it up. Oh well. To update , the picks Vitalhub has been undergoing a re-rating surge which hopefully
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 28, 2023 7:02am
New Press Release - OPSENS OBTAINS REGULATORY CLEARANCE OF ARRANGEMENT IN THE UNITED STATES AND CANADA; REGULATORY APPROVALS CONDITION SATISFIED
All amounts in this press release are in Canadian dollars.Clearance under both the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the Investment Canada Act has been achieved and therefore the mutual closing condition with respect to regulatory approvals in the arrangement...
read article.
(18)
•••
GoldenArm1
X
View Profile
View Bullboard History
Comment by
GoldenArm1
on Nov 27, 2023 1:30pm
RE:RE:OPSENS ANNOUNCES FOURTH QUARTER RESULTS
Like I said awhile back when I sold. They are not profitable and I can't see them profitable until much later. You can buy now and wait but I'm waiting for positive news on the profitability
...more
(39)
•••
tannin
X
View Profile
View Bullboard History
Comment by
tannin
on Nov 27, 2023 1:22pm
RE:RE:OPSENS ANNOUNCES FOURTH QUARTER RESULTS
also not happy with the deal.....but think it's done and dusted.......hard to replace in my portfolio......any ideas ? For others, you might look at KSI.
(1974)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Comment by
Possibleidiot01
on Nov 25, 2023 4:14pm
RE:OPSENS ANNOUNCES FOURTH QUARTER RESULTS
Results were great ; not happy with the deal . Cash and cash equivalents of $17.5 million at November 30, 2022 ($23.8 million at August 31, 2022). Cash and cash equivalents of $20.5 million at May 31,
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments